BeiGene, Ltd. anticipated opening of biologics manufacturing facility and clinical R&D center at the Princeton West Innovation Campus in Hopewell, New Jersey, in July 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
153.1 USD | +0.26% | -8.53% | -15.11% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.11% | 15.97B | |
+9.83% | 118B | |
+10.80% | 106B | |
-10.84% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
+6.62% | 14.03B | |
+17.53% | 11.67B | |
-30.73% | 7.55B |
- Stock Market
- Equities
- BGNE Stock
- News BeiGene, Ltd.
- BeiGene, Ltd. Anticipates Opening of Biologics Manufacturing Facility and Clinical R&D Center at the Princeton West Innovation Campus in Hopewell, New Jersey, in July 2024